Ritussin Dm
NDC Package 53807-409-08
Package Information
Ritussin Dm is do not take more than 6 doses in any 24-hour periodagedoseadults and children 12 years of age and over2 teaspoonfuls every 4 hourschildren 6 years to under 12 years of age1 teaspoonful every 4 hourschildren 2 years to under 6 years of age1/2 teaspoonful every 4 hoursunder 2 years of ageask a doctor. Marketed by Rij Pharmaceutical Corporation, this product is identified by NDC 53807-409 and is authorized under FDA application part341.
Identification & Billing
- RxCUI: 996520 - dextromethorphan HBr 20 MG / guaiFENesin 200 MG in 10 mL Oral Solution
- RxCUI: 996520 - dextromethorphan hydrobromide 2 MG/ML / guaifenesin 20 MG/ML Oral Solution
- RxCUI: 996520 - dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG per 5 ML Oral Solution
- RxCUI: 996520 - dextromethorphan hydrobromide 15 MG / guaifenesin 150 MG per 7.5 ML Oral Solution
- RxCUI: 996520 - dextromethorphan hydrobromide 20 MG / guaifenesin 200 MG per 10 ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 53807 - Rij Pharmaceutical Corporation
- 53807-409 - Ritussin Dm
- 53807-409-08 - 236 mL in 1 BOTTLE
- 53807-409 - Ritussin Dm
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (53807-409). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 53807-409-08 identifies a specific commercial package of 236 ml in 1 bottle of Ritussin Dm, labeled by Rij Pharmaceutical Corporation. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Rij Pharmaceutical Corporation on March 16, 1999. The current certification is valid through December 31, 2019.
How is this Rij Pharmaceutical Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 53807040908. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.